INTERNATIONAL PATENT: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "DIRECT IN VIVO GENE EDITING OF LUNG STEM CELLS FOR DURABLE THERAPY OF GENETIC LUNG DISEASE"

GENEVA, Dec. 31 -- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (210 W. 7th StreetAustin, Texas 78701) filed a patent application (PCT/US2025/033938) for "DIRECT IN VIVO GENE EDITING OF LUNG STEM CELLS FOR DURABLE THERAPY OF GENETIC LUNG DISEASE" on Jun 17, 2025. With publication no. WO/2025/264646, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHATTERJEE, Sumanta (c/o UT Southwestern Medical CenterDept. of Biochemistry - 6000 Harry Hines Blvd.Dallas, Texas 75390), SUN, Yehui (c/o UT Southwestern Medical Cente...